WVE - Company ID 0001631574
The table below shows Wave Life Sciences Ltd.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $42.73M | $108.30M | $113.31M | $3.65M | $40.96M | $20.08M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $182.78M | $159.68M | $130.01M | $115.86M | $121.88M | $130.94M |
| SG&A |
Wave Life Sciences Ltd. reported annual revenue of $42.73M for fiscal year 2025. That is down 60.5% from $108.30M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.49M (FY 2016) to $42.73M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $75.33M |
| $59.02M |
| $51.29M |
| $50.51M |
| $46.10M |
| $42.51M |
| Operating income | -$215.38M | -$110.40M | -$68.00M | -$162.72M | -$127.02M | -$153.38M |
| Income tax | $0.00 | $0.00 | -$677.00K | $681.00K | -$204.00K | -$841.00K |
| Net income | -$204.38M | -$97.01M | -$57.51M | -$161.82M | -$122.25M | -$149.91M |
| EPS (diluted) | -$1.21 | -$0.70 | -$0.54 | -$2.05 | -$2.36 | - |